Can Mounjaro Cause Breast Cancer? (October 2026)

01 · The core answer

Can Mounjaro cause breast cancer? What the product information says

No, breast cancer is not listed as a side effect of Mounjaro in the Summary of Product Characteristics or the patient leaflet.¹¹³ If a website tells you Mounjaro definitely causes or definitely prevents breast cancer, treat it with caution.

Mounjaro is licensed in the UK for weight management and type 2 diabetes.¹ It works by activating the GIP and GLP-1 receptors, which helps regulate appetite and slows how quickly the stomach empties.¹ Nothing in that description is a breast-specific mechanism.

02 · Your decision

What to do if you are worried about cancer and Mounjaro

Tell the prescriber about your full history before you start, because that is what the consultation is for. At EverydayMeds, every order is reviewed by a GPhC-registered prescriber, and if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Mention any previous cancer, any close family history, and any current investigations.

If you have had breast cancer, the decision is individual. It depends on your treatment, your oncology team's advice and your own preferences. Do not start or stop anything on the strength of a headline. Ask your oncology team or GP whether weight management treatment fits your plan, then take that advice into your consultation.

If you are ready to look at treatment, you can see the Mounjaro pen, prices and consultation, or read about our wider weight loss clinic first.

03 · Thyroid cancer and GLP-1s

Thyroid cancer and GLP-1 medicines

Thyroid cancer is the cancer question that people most often raise about GLP-1 medicines, and it deserves a proper conversation rather than a shrug.

In rodent studies tirzepatide caused thyroid C-cell tumours; it is not known whether this applies to humans, and no increase has been shown in human trials.¹¹³ Tell your prescriber if you or a close relative have had medullary thyroid cancer or the inherited condition MEN 2. Routine thyroid monitoring is not required for most people.

Different types of thyroid cancer are not interchangeable. If you have had papillary thyroid cancer, or a rarer type such as medullary thyroid cancer, or a family history of either, the answer is specific to you. We have separate pages on medullary thyroid cancer and Mounjaro, on taking Mounjaro after papillary thyroid cancer, and on thyroid tumours.

The practical rule is simple. Disclose any thyroid history, any thyroid lump or neck swelling, and any family history of thyroid cancer. Do not guess whether it matters. Let the prescriber, and where needed your specialist, decide.

04 · Pancreatic and colon cancer

Pancreatic and colon cancer questions

Pancreatic and colon cancer are not listed side effects of Mounjaro, but the pancreas has its own cautions in the product information, so read them.¹¹³

We keep two things apart. Inflammation or pain in the pancreas is one subject, and cancer is a different one. Our Mounjaro pancreatic cancer page goes into this further.

For the bowel, the same plain approach applies. Constipation and diarrhoea are common when starting Mounjaro, because food moves through the gut differently. That does not make every change harmless, though. Blood in your stool, bowel changes that persist or worsen, or unexplained pain should be checked by your GP rather than put down to the medicine.

If you notice something that you think could be a side effect, report it through the Yellow Card scheme, which the MHRA runs.¹⁹ Reports from patients and clinicians are how safety signals are spotted over time.

05 · Weight loss and cancer signs

Weight loss, cancer and warning signs

Weight loss on Mounjaro is the intended effect, whereas unexplained weight loss is a symptom that doctors take seriously.

The useful distinction is context. If you are on treatment, eating less and losing weight steadily as your prescriber expects, that is the medicine doing its job. If you lose weight when you are not trying, lose it far faster than expected, or feel unwell alongside it, speak to your GP.

For breast health, the sensible approach is simple. Know what is normal for your breasts, attend your routine screening invitations, and see your GP promptly about any new lump, skin change or nipple change. Our page on breast lumps and Mounjaro covers that in more depth.

06 · Mounjaro after breast cancer

Mounjaro after breast cancer

Whether you can take Mounjaro after breast cancer is a decision for you, your oncology team and the prescriber together, not something a web page can settle.

Ask your oncology team or GP whether weight management treatment is compatible with your follow-up plan. Bring a list of any current medicines to your consultation, including hormone therapies. If you are also taking other medicines, the prescriber needs the full picture, because Mounjaro slows stomach emptying and that is relevant to how some oral medicines are absorbed.¹

We would rather you wait for advice than start on assumptions. A prescriber who can see your history will either proceed, ask for specialist input, or decline and refund you in full.

07 · Reading cancer headlines

How to read headlines about GLP-1s and cancer

Headlines about GLP-1 medicines and cancer usually blur four different things: an animal study, an observational database study, a clinical trial and a regulator's label. They carry very different weight, and it helps to know which you are reading.

An animal study tells researchers where to look, but it does not tell you what happens in a person. An observational study can find associations, yet it cannot prove cause and effect, because people who are prescribed a medicine differ from those who are not. A trial is designed to answer one question well, but it may be too short or too small to answer questions about rare, slow-developing outcomes. The product information is the regulator's running summary of what is established.

It also helps to know what the medicine is. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once, GIP and GLP-1.¹

08 · Risk factors and medicines

Other medicines and risk factors people ask about

For general risk, the NHS website and your GP are the right places, since breast cancer risk involves age, family history, previous breast conditions, hormone exposure and lifestyle. Your GP can discuss your own risk and whether you qualify for any extra surveillance.

For medicines, the rule is the same for any prescription. Ask the prescriber or pharmacist, read the leaflet and report anything unexpected. Do not stop a hormone therapy or any cancer-related medicine because of something you read about Mounjaro. Stopping prescribed treatment without advice can do real harm.

Supplements sold as "natural GLP-1 boosters" are not equivalents of prescribed treatment, are not regulated for this use and have no comparable trial evidence. Unlicensed "research" peptides, including retatrutide, which has no UK licence, have no safety data and no regulated supply chain, so avoid them.

09 · Safe supply and monitoring

Why regulated supply and review matter

If you are worried about safety, where your medicine comes from is part of the answer. Counterfeit and unregulated products circulate, and the MHRA publishes alerts about them.⁷ A seller offering to supply without a consultation or prescription is a warning sign, however low the price.

EverydayMeds is a GPhC-registered pharmacy (registration 9012878). We supply Mounjaro through official LillyDirect supply, so you receive genuine KwikPens sourced directly from Eli Lilly's UK distribution. Every order starts with a free online consultation reviewed by a GPhC-registered prescriber.

Monitoring continues after the first order. Our ongoing monthly reviews, dose-titration and follow-up assessments are carried out by the prescribing team, with side-effect support if you need it. Repeat orders re-check suitability, and nothing ships automatically. If your health changes, including a new diagnosis or new investigations, tell us before your next order.

Keep going with routine health checks too, including breast screening, cervical screening and any monitoring your GP has set up. Treatment for weight management sits alongside those checks and never replaces them.

10 · Serious side effects

Serious side effects: when to get help straight away

Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹